SCHEMBL29407669

SCHEMBL29407669

COc1ccc(-c2c(I)n(C)c3ncnc(N)c23)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRC P12931 8/20 0.52
▸ KDR P35968 6/20 0.52
▸ ABL1 P00519 5/20 0.52
▸ EGFR P00533 3/20 0.52
▸ ABL2 P42684 2/20 0.52
▸ TEK Q02763 4/20 0.51
▸ PI4KB Q9UBF8 2/20 0.51
▸ HCK P08631 2/20 0.51
▸ PIK3CD O00329 1/20 0.51
▸ PIK3CA P42336 1/20 0.51
▸ PIK3CB P42338 1/20 0.51
▸ MTOR P42345 1/20 0.51
▸ PIK3CG P48736 1/20 0.51
▸ EPHB4 P54760 1/20 0.51
▸ PRKDC P78527 1/20 0.51
▸ RIPK2 O43353 3/20 0.48
▸ LCK P06239 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22658699 1.00 SRC (0.52) SRCKDRABL1EGFRABL2
SCHEMBL29552498 0.86 NUDT14 (0.60) SRCKDRABL1EGFRTEK
SCHEMBL24458356 0.86 NUDT14 (0.60) SRCKDRABL1EGFRTEK
SCHEMBL22675996 0.85 SRC (0.53) SRCKDRABL1EGFRABL2
SCHEMBL26108066 0.84 NUDT14 (0.46) SRCKDRABL1EGFRABL2
SCHEMBL30582543 0.84 KDM4E (0.49) SRCKDRTEKRIPK2KDM4E
SCHEMBL26105843 0.84 KDM4E (0.49) SRCKDRTEKRIPK2KDM4E
SCHEMBL22658885 0.82 KDR (0.44) SRCKDRABL1EGFRTEK
SCHEMBL24458871 0.82 RET (0.47) SRCKDRABL1EGFRTEK
SCHEMBL25716098 0.81 LCK (0.45) SRCKDRABL1EGFRABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874707-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2025-04-25 — — CN disclosed
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-114126620-B FGFR inhibitors and methods of use thereof 传达治疗有限公司 2024-12-31 — — CN disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
EP-3968999-A1 FGFR INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2022-03-23 — — EP disclosed
CN-114126620-A FGFR inhibitors and methods of use thereof 传达治疗有限公司 2022-03-01 — — CN disclosed
Send feedback